FILING ANALYSIS · WEDNESDAY, OCTOBER 28
Bausch Health Companies Inc. BHC — 8-K: Results of Operations and Financial Condition
positive
Bausch Health Companies Inc. reported strong Q3 2026 results, with 10% revenue growth and 32% adjusted EBITDA growth, and raised its full-year guidance, also announcing a $50 million share repurchase program to offset dilution from management equity awards
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →